ZFHX3) have been identified as common susceptibility genes for AF in European and
Japanese populations. 26 Most importantly, AF is strongly associated with an approximately …

Cardiac arrhythmias can follow disruption of the normal cellular electrophysiological
processes underlying excitable activity and their tissue propagation as coherent wavefronts …

Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular
tachycardia: Are all beta-blockers equivalent? - Abstract - Europe PMC Sign in | Create an …

Antiarrhythmics, like many other drugs, produce widely divergent actions in patients: the
spectrum of responses range from suppression of highly symptomatic arrhythmias to …

Application of resuscitation science to improve patient care and outcomes requires effective
strategies for education and implementation. Systematic reviews suggest that there are …

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is induced by emotions or
exercise in patients without organic heart disease and may be polymorphic or bidirectional …

Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an
inheritable cardiac disease predisposing to malignant ventricular arrhythmias. Objective We …

BACKGROUND: The mainstay of therapy for catecholaminergic polymorphic ventricular
tachycardia (CPVT) is maximal doses of β-blockers. However, although β-blockers prevent …

QT interval prolongation is so frequently associated with torsades de pointes (TdP) that it
has come to be recognized as a surrogate marker of this unique tachyarrhythmia. However …

Background—Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by
mutations in the cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) and can be …